CyRhmU.jpeg
²é¿´: 708  |  »Ø¸´: 4
µ±Ç°Ö÷ÌâÒѾ­´æµµ¡£

xiaohezi7844

½ûÑÔ (ÖªÃû×÷¼Ò)

[½»Á÷] FDA08ÄêÅú×¼µÄÒ©Æ·

FDA08ÄêÒ»ÔÂÅú×¼µÄÒ©Æ·£¨ÉÏ£©
ÉêÇëºÅ   »îÐԳɷ֠  ¹«Ë¾  Åú×¼ÀàÐÍ   Åú×¼ÈÕ    ¼ÁÐÍ   ÊÊÓ¦Ö¢
NDA # 021924  LEVOTHYROXINE SODIUM¼××´ÏÙËØÄÆ  INST BIOCHIMIQUE  Supplement  01/01/2008  ½ºÄÒ  ¼××´ÏÙ¹¦Äܲ»×㲡£¬´¹ÏÙTSHÒÖÖÆ
NDA # 018031  HYDROCHLOROTHIAZIDE; PROPRANOLOL HYDROCHLORIDEÇâÂÈàçàº/ÑÎËáÆÕÝÁÂå¶û  WYETH PHARMS INC  Labeling Revision  01/02/2008  Æ¬¼Á  ¸ßѪѹ
NDA # 020356  NISOLDIPINEÄáË÷µØÆ½  SCIELE PHARMA INC  Formulation Revision  01/02/2008  ½ºÄÒ¼Á£¨ER£©  ¸ßѪѹ
NDA # 021438  PROPRANOLOL HYDROCHLORIDEÑÎËáÆÕÝÁÂå¶û  RELIANT PHARMS  Labeling Revision  01/02/2008  Æ¬¼Á£¨ER£©  ¸ßѪѹ
NDA # 022044  METFORMIN HYDROCHLORIDE; SITAGLIPTIN PHOSPHATEÑÎËá¶þ¼×Ë«ëÒÁ×ËáÎ÷ËûÁÐÍ¡  MERCK  Labeling Revision  01/02/2008  Æ¬¼Á  2ÐÍÌÇÄò²¡
NDA # 020375  ESTRADIOL´Æ¶þ´¼  BAYER HLTHCARE  Labeling Revision  01/03/2008  Ä¤¼Á£¨ER£©  ´Æ¼¤ËØ
NDA # 020522  SOMATROPIN RECOMBINANT»ùÒòÖØ×éÈËÉú³¤¼¤ËØ  GENENTECH  Manufacturing Change or Addition  01/03/2008  ×¢Éä¼Á  Éú³¤ËØ
ANDA # 077963  GRANISETRON HYDROCHLORIDEÑÎËá¸ñÀ­Ë¾Çí  TEVA PARENTERAL  Approval  01/03/2008  ×¢Éä¼Á  »¯ÁÆÖ¹ÍÂ
ANDA # 078596  METFORMIN HYDROCHLORIDEÑÎËá¶þ¼×Ë«ëÒ  INTERPHARM  Approval  01/03/2008  Æ¬¼Á£¨ER£©  ½µÌÇÒ©
ANDA # 077643  TOPIRAMATE HYDROCHLORIDEÑÎËáÍÐßÁõ¥  COBALT  Tentative Approval  01/04/2008  Æ¬¼Á  ¿¹ñ²ðïÒ©
ANDA # 078769  IBUPROFEN; OXYCODONE HYDROCHLORIDE²¼Âå·ÒÑÎËáôÇ¿¼Íª  ACTAVIS ELIZABETH  Approval  01/04/2008  Æ¬¼Á  ÕòÍ´Ò©
NDA # 050207  ERYTHROMYCIN ETHYLSUCCINATEçúÒÒºìÃ¹ËØ  ABBOTT  Labeling Revision  01/05/2008  ¿ÅÁ£¼Á  ¿¹ÉúËØ
NDA # 050611  ERYTHROMYCINºìÃ¹ËØ  ABBOTT  Labeling Revision  01/05/2008  Æ¬¼Á£¬°üÒ¿ÅÁ£  ¿¹ÉúËØ
NDA # 021368  TADALAFILËû´ïÄÇ·Ç  LILLY  New Dosage Regimen  01/07/2008  Æ¬¼Á  ÐÔ²ªÆð¹¦ÄÜÕϰ­
ANDA # 065434  CEFDINIRÍ·æßµØÄá  AUROBINDO PHARMA  Approval  01/07/2008  ½ºÄÒ¼Á  ¿¹ÉúËØ
ANDA # 077062  FENTANYL·ÒÌ«Äá  ABRIKA PHARMS  Control Supplement  01/07/2008  Ä¤¼Á£¨ER£©  ÕòÍ´Ò©
ANDA # 078151  TERBUTALINE SULFATEÁòËáÌØ²¼ËûÁÖ  AKORN  Approval  01/07/2008  ×¢Éä¼Á  Æ½´­Ò©
NDA # 017963  METOPROLOL TARTRATE¾ÆÊ¯ËáÃÀÍÐÂå¶û  NOVARTIS  Labeling Revision  01/08/2008  Æ¬¼Á  ¸ßѪѹ
NDA # 018303  HYDROCHLOROTHIAZIDE; METOPROLOL TARTRATEÇâÂÈàç຾ÆÊ¯ËáÃÀÍÐÂå¶û  NOVARTIS  Labeling Revision  01/08/2008  Æ¬¼Á  ¸ßѪѹ
NDA # 019649  RIMANTADINE HYDROCHLORIDEÑÎËá½ð¸ÕÒÒ°·  FOREST LABS  Labeling Revision  01/08/2008  Æ¬¼Á  ¿¹²¡¶¾
ANDA # 077129  RIVASTIGMINE TARTRATE¾ÆÊ¯ËῨ°ÍÀ­Í¡  WATSON LABS  Approval  01/08/2008  ½ºÄÒ¼Á  ¿¹ADÒ©
ANDA # 077297  GRANISETRON HYDROCHLORIDEÑÎËá¸ñÀ­Ë¾Çí  SICOR PHARMS  Tentative Approval  01/08/2008  ×¢Éä¼Á  »¯ÁÆÖ¹ÍÂ
ANDA # 077917  PRAVASTATIN SODIUM ÆÕ·¥ËûÍ¡ÄÆ  LUPIN PHARMS  Approval  01/08/2008  ½ºÄÒ¼Á  ¸ß֬Ѫ֢
ANDA # 078090  GRANISETRON HYDROCHLORIDEÑÎËá¸ñÀ­Ë¾Çí  ABRAXIS PHARM  Tentative Approval  01/08/2008  ×¢Éä¼Á  »¯ÁÆÖ¹ÍÂ
ANDA # 078403  SERTRALINE HYDROCHLORIDEÑÎËáÉáÇúÁÖ  WOCKHARDT  Approval  01/08/2008  Æ¬¼Á  ¿¹ÒÖÓôÒ©
NDA # 021490  ETHINYL ESTRADIOL; NORETHINDRONEȲ´Æ´¼È²ÅµÍª  WARNER CHILCOTT  Labeling Revision  01/09/2008  ¾×½ÀƬ  ±ÜÔÐÒ©
ANDA # 040094  ACETAMINOPHEN; HYDROCODONE BITARTRATE¶ÔÒÒõ£°±»ù·Ó+ÖØ¾ÆÊ¯Ëá¿É´ýÒòͪ  WATSON LABS  Supplier Addition  01/09/2008  Æ¬¼Á  ÕòÍ´Ò©
ANDA # 077051  FENTANYL·ÒÌ«Äá  LAVIPHARM LABS  Control Supplement  01/09/2008  Ä¤¼Á£¨ER£©  ÕòÍ´Ò©
ANDA # 076507  FLUCONAZOLE·ú¿µßò  TARO  Control Supplement  01/09/2008  Æ¬¼Á  ¿¹¾úÒ©
ANDA # 078339  GEMCITABINE¼ªÎ÷Ëû±ö  HOSPIRA INC  Tentative Approval  01/09/2008  ×¢Éä¼Á  ¿¹Ö×ÁöÒ©
NDA # 021610  OXYMORPHONE HYDROCHLORIDEÑÎËáôÇÂð·Èͪ  ENDO PHARMS  Control Supplement  01/10/2008  Æ¬¼Á£¨ER£©  ÕòÍ´Ò©
NDA # 021658  CICLESONIDE»·Ë÷Äε  NYCOMED US INC  Approval  01/10/2008  ÎüÈë¼Á  Æ½´­Ò©
ANDA # 065342  CEFTRIAXONEÍ·æßÇúËÉ  HIKMA FARMACEUTICA  Approval  01/10/2008  ×¢Éä¼Á  ¿¹ÉúËØ
ANDA # 065372  POLYMYXIN B SULFATEÁòËá¶àÕ³¾úËØB  ABRAXIS PHARM PRODS  Approval  01/10/2008  ×¢Éä¼Á  ¶àëÄÀ࿹ÉúËØ
ANDA # 078213  PROPRANOLOL HYDROCHLORIDEÆÕÝÁÂå¶û  NORTHSTAR HLTHCARE  Approval  01/10/2008  Æ¬¼Á  ¸ßѪѹ
NDA # 021153  ESOMEPRAZOLE MAGNESIUM°£Ë÷ÃÀÀ­ßòþ  ASTRAZENECA  Labeling Revision  01/11/2008  ½ºÄÒ£¨DR£©  PPI
NDA # 021773  EXENATIDE SYNTHETICÀà¸ßѪÌÇÒò×Ó  AMYLIN  Labeling Revision  01/11/2008  ×¢Éä¼Á  ½µÌÇÒ©
ANDA # 065305  CEFTRIAXONE SODIUMÍ·æßÇúËÉÄÆ  LUITPOLD  Approval  01/11/2008  ×¢Éä¼Á  ¿¹ÉúËØ
ANDA # 077344  DONEPEZIL HYDROCHLORIDEÑÎËá¶àÄÎßßÆë  TEVA PHARMS  Tentative Approval  01/11/2008  Æ¬¼Á  ¿¹ADÒ©
ANDA # 077620  GLIPIZIDE; METFORMIN HYDROCHLORIDEßÁàºË«ëÒÆ¬  CARACO  Approval  01/11/2008  Æ¬¼Á  ½µÌÇÒ©
ANDA # 077631  CETIRIZINE HYDROCHLORIDEÑÎËáÎ÷ÌæÀûຠ CARACO  Approval  01/11/2008  Æ¬¼Á  ¿¹¹ýÃôÒ©
ANDA # 078069  OXCARBAZEPINE°Â¿¨Î÷ƽ  BRECKENRIDGE PHARM  Approval  01/11/2008  Æ¬¼Á  ¿¹ñ²ðïÒ©
NDA # 020998  CELECOXIBÈûÀ´Îô²¼  GD SEARLE  Labeling Revision  01/14/2008  ½ºÄÒ¼Á  ¹Ø½ÚÑ×
NDA # 021083  SIROLIMUSÎ÷ÂÞĪ˾  WYETH PHARMS INC  Efficacy Supplement with Clinical Data to Support  01/14/2008  ¿Ú·þÈÜÒº  ÃâÒßÒÖÖÆ¼Á
ANDA # 076273  CLOPIDOGREL BISULFATEÂÈßÁ¸ñÀ×ÁòËáÇâÑΠ DR REDDYS LABS INC  Approval  01/14/2008  Æ¬¼Á  ¿¹ÄýѪҩ
ANDA # 078145  KETOROLAC TROMETHAMINEͪ¿©Ëá°±¶¡Èý´¼  LUITPOLD  Approval  01/14/2008  ×¢Éä¼Á  Ö¹Í´Ò©
ANDA # 078198  GRANISETRON HYDROCHLORIDEÑÎËá¸ñÀ­Ë¾Çí  APOTEX  Tentative Approval  01/14/2008  ×¢Éä¼Á  »¯ÁÆÖ¹ÍÂ
BLA # 125104  NATALIZUMABÄÇËûÖéµ¥¿¹  BIOGEN IDEC  Supplement  01/14/2008  ×¢Éä¼Á  ¿¹Ö×ÁöÒ©
08ÄêÒ»ÔÂÅú×¼µÄÒ©Æ·£¨Ï£©
NDA # 021350  FENOFIBRATE·Çŵ±´ÌØ  SKYEPHARMA AG  Labeling Revision  01/15/2008  Æ¬¼Á  ¸ß֬Ѫ֢
ANDA # 077793  PRAVASTATIN SODIUMÆÕ·¥ËûÍ¡ÄÆ  TEVA PHARMS  Approval  01/15/2008  Æ¬¼Á  ¸ß֬Ѫ֢
ANDA # 078343  CETIRIZINE HYDROCHLORIDEÑÎËáÎ÷ÌæÀûຠ DR REDDYS LABS LTD  Approval  01/15/2008  Æ¬¼Á  ¿¹¹ýÃôÒ©
ANDA # 078662  DONEPEZIL HYDROCHLORIDEÑÎËá¶àÄÎßßÆë  ROXANE  Tentative Approval  01/15/2008  Æ¬¼Á  ¿¹ADÒ©
NDA # 021071  ROSIGLITAZONE MALEATEÂíÀ´ËáÂÞ¸ñÁÐͪ  SB PHARMCO  Labeling Revision  01/16/2008  Æ¬¼Á  ½µÌÇÒ©
NDA # 021426  SOMATROPIN RECOMBINANT»ùÒòÖØ×éÈËÉú³¤¼¤ËØ  SANDOZ  Formulation Revision  01/16/2008  ×¢Éä¼Á  Éú³¤ËØ
ANDA # 077570  FLUTICASONE PROPIONATE±ûËá·úÌæ¿¨ËÉ  HI TECH PHARMA  Approval  01/16/2008  ÆøÎí¼Á  ÌÇÆ¤Öʼ¤ËØ
ANDA # 078143  FLUOXETINE HYDROCHLORIDEÑÎËá·úÎ÷Í¡  WOCKHARDT  Approval  01/16/2008  ½ºÄÒ¼Á  ¿¹ÒÖÓôÒ©
ANDA # 078477  AMLODIPINE BESYLATE±½»ÇËá°±ÂÈµØÆ½  INTERPHARM  Approval  01/16/2008  Æ¬¼Á  ¸ßѪѹ
ANDA # 078598  CIPROFLOXACIN HYDROCHLORIDEÑÎËá»·±ûɳÐÇ  PHARMAFORCE  Approval  01/16/2008  µÎ¼Á  ¿¹ÉúËØ
NDA # 021087  OSELTAMIVIR PHOSPHATEÁ×Ëá°Â˾ËûΤ  ROCHE  Labeling Revision  01/17/2008  »ìÐüÒº  ¿¹²¡¶¾Ò©
NDA # 021471  AVOBENZONE; ECAMSULE; OCTOCRYLENE; TITANIUM DIOXIDE°¢ÎÖ±½ËÉ/ÒÀÝ¨Êæ/°Â¿ËÁ¢ÁÖ/¶þÑõ»¯îÑ  LOREAL USA  Labeling Revision  01/17/2008  Èé¸à  ·Àɹ¼Á
NDA # 022067  PREDNISOLONE ACETATE´×ËáÆÃÄáËÉÁú  TARO  Approval  01/17/2008  »ìÐüÒº  ÌÇÆ¤Öʼ¤ËØ
ANDA # 076740  NIMODIPINEÄáĪµØÆ½  BANNER PHARMACAPS  Approval  01/17/2008  ½ºÄÒ  ¸ßѪѹ
NDA # 019537  CIPROFLOXACIN HYDROCHLORIDEÑÎËá»·±ûɳÐÇ  BAYER PHARMS  Labeling Revision  01/18/2008  Æ¬¼Á  ¿¹ÉúËØ
NDA # 020780   CIPROFLOXACIN »·±ûɳÐÇ  BAYER PHARMS  Labeling Revision  01/18/2008  »ìÐüÒº  ¿¹ÉúËØ
NDA # 021176  COLESEVELAM HYDROCHLORIDEÑÎËῼÀ´Î¬ÂØ  DAIICHI SANKYO  New or Modified Indication  01/18/2008  Æ¬¼Á  ½µÌÇÒ©
NDA # 021180  ETHINYL ESTRADIOL; NORELGESTROMINÒÒȲ´Æ¶þ´¼/¼×»ùÔÐͪ  ORTHO MCNEIL PHARM  Labeling Revision  01/18/2008  Ä¤¼Á£¨ER£©  ±ÜÔÐÒ©
NDA # 021229  OMEPRAZOLE MAGNESIUM°ÂÃÀÀ­ßòþ  ASTRAZENECA  Labeling Revision  01/18/2008  Æ¬¼Á£¨ER£©  PPI
NDA # 021473  CIPROFLOXACIN; CIPROFLOXACIN HYDROCHLORIDE»·±ûɳÐÇ£¬ÑÎËá»·±ûɳÐÇ  BAYER PHARMS  Labeling Revision  01/18/2008  Æ¬¼Á£¨ER£©  ¿¹ÉúËØ
NDA # 022107  ALISKIREN HYDROCHLOROTHIAZIDE°¢Àû¼ªÂØ/ÇâÂÈàçຠ NOVARTIS PHARMS  Approval  01/18/2008  Æ¬¼Á  ¸ßѪѹ
NDA # 022187  ETRAVIRINEÒÁËûΤ¶÷  TIBOTEC  Approval  01/18/2008  Æ¬¼Á  ¿¹²¡¶¾Ò©
ANDA # 077255  LANSOPRAZOLEÀ¼Ë÷À­ßò  TEVA PHARMS  Tentative Approval  01/18/2008  ½ºÄÒ¼Á£¨DR£©  PPI
BLA # 103792  TRASTUZUMABÇúÍ×Öéµ¥¿¹  GENENTECH  Supplement  01/18/2008  ×¢Éä¼Á  ¿¹Ö×ÁöÒ©
BLA # 125057  ADALIMUMAB°¢´ïľµ¥¿¹  ABBOTT  Supplement  01/18/2008  ×¢Éä¼Á  ¹Ø½ÚÑס¢ÒøÐ¼²¡µÈ
NDA # 017628  TOLMETIN SODIUMÍжûÃ×Í¡ÄÆ  ORTHO MCNEIL PHARM  Labeling Revision  01/22/2008  ½ºÄÒ¼Á  NSAID
NDA # 021506  MICAFUNGIN SODIUMÃ׿¨·Ò¾»ÄÆ  ASTELLAS  New or Modified Indication  01/22/2008  ×¢Éä¼Á  ¿¹¾úÒ©
NDA # 050580  AZTREONAM°±ÇúÄÏ  BRISTOL MYERS SQUIBB  Labeling Revision  01/22/2008  ×¢Éä¼Á  ¿¹ÉúËØ
NDA # 021538  SOMATROPIN rDNA ORIGINALÈËÉú³¤¼¤ËØÔ­Ê¼rDNA  CANGENE CORP  Approval  01/23/2008  ×¢Éä¼Á  Éú³¤ËØ
NDA # 050813  AMOXICILLIN°¢ÄªÎ÷ÁÖ  MIDDLEBROOK PHARMA  Approval  01/23/2008  Æ¬¼Á£¨ER£©  ¿¹ÉúËØ
ANDA # 077453  OXYTOCINËõ¹¬ËØ  TEVA PARENTERAL  Approval  01/24/2008  ×¢Éä¼Á  Òý²ú¡¢²úºó³öѪµÈ
BLA # 103705  RITUXIMABÀûÍ×Îôµ¥¿¹  GENENTECH  Supplement  01/24/2008  ×¢Éä¼Á  ¿¹Ö×ÁöÒ©
NDA # 018827  BETAMETHASONE DIPROPIONATE; CLOTRIMAZOLE¶þ±ûËá±¶ËûÃ×ËÉ¿Ëùßò  SCHERING  Labeling Revision  01/25/2008  Èé¸à  ¿¹¾úÒ©
NDA # 020010  BETAMETHASONE DIPROPIONATE; CLOTRIMAZOLE¶þ±ûËá±¶ËûÃ×ËÉ¿Ëùßò  SCHERING PLOUGH RES  Labeling Revision  01/25/2008  Ï´Òº  ¿¹¾úÒ©
NDA # 021166  ESTRADIOL´Æ¶þ´¼  ASCEND  Labeling Revision  01/25/2008  Äý½º¼Á  ´Æ¼¤ËØ
NDA # 022023  FOSAPREPITANT DIMEGLUMINE°¢ÈðßÁ̹¶þ¼×ÆÏ°·  MERCK CO INC  Approval  01/25/2008  ·ÛÄ©¼Á  Ö¹ÍÂÒ©
ANDA # 040517  METHADONE HYDROCHLORIDEÑÎËáÃÀɳͪ  MALLINCKRODT  Control Supplement  01/26/2008  Æ¬¼Á  Õò¾²¼Á
ANDA # 040545  ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE¶ÔÒÒõ£°±»ù·Ó/ÑÎËáôÇÇâ¿É´ýͪ  MALLINCKRODT  Control Supplement  01/26/2008  Æ¬¼Á  Õò¾²¼Á
ANDA # 075618  ACETAMINOPHEN/BUTALBITAL/CAFFEINE/CODEINE PHOSPHATE¶ÔÒÒõ£°±»ù·Ó,²¼Ëû±ÈÍ×,¿§·ÈÒò,Á×Ëá¿É´ýÒò  WEST WARD  Supplier Addition  01/26/2008  ½ºÄÒ¼Á  Õò¾²¼Á
ANDA # 087757  ACETAMINOPHEN; HYDROCODONE BITARTRATE¶ÔÒÒõ£°±»ù·Ó+ÖØ¾ÆÊ¯Ëá¿É´ýÒòͪ  SCHWARZ PHARMA  Control Supplement  01/26/2008  Æ¬¼Á  ÕòÍ´Ò©
NDA # 020639  QUETIAPINE FUMARATE¸»ÂíËá¿üÁòƽ  ASTRAZENECA  Labeling Revision  01/28/2008  Æ¬¼Á  ¾«Éñ·ÖÁÑÖ¢
NDA # 022157  LEVOCETIRIZINE DIHYDROCHLORIDEÑÎËá×óÐýÎ÷ÌæÀûຠ UCB INC  Approval  01/28/2008  ¿Ú·þÈÜÒº  ¿¹¹ýÃôÒ©
ANDA # 040762  PHENDIMETRAZINE TARTRATE¾ÆÊ¯Ëá±½¼×ÇúÇØ  AMIDE PHARM  Approval  01/28/2008  Æ¬¼Á  ·ÊÅÖÖ¢
ANDA # 040874  DIPYRIDAMOLE Ë«à×´ïĪ  ZYDUS PHARMS USA INC  Approval  01/28/2008  Æ¬¼Á  ¿¹ÑªË¨
ANDA # 065185  BLEOMYCIN SULFATEÁòËᲩÀ´Ã¹ËØ  ABRAXIS PHARM  Approval  01/28/2008  ×¢Éä¼Á  ¿¹Ö×Áö¿¹ÉúËØ
NDA # 021476  ESZOPICLONEÓÒ×ôÆ¥¿Ë¡  SEPRACOR  Labeling Revision  01/29/2008  Æ¬¼Á  Ê§Ãß
ANDA # 040776  DEXTROAMPHETAMINE SULFATEÓÒÐý±½±û°·ÁòËáÑΠ OUTLOOK PHARMS  Approval  01/29/2008  ¿Ú·þÈÜÒº  ·ÊÅÖÖ¢
ANDA # 077630  TAMSULOSIN HYDROCHLORIDEÑÎËá̹Ë÷ÂÞÐÁ  TEVA PHARMS  Tentative Approval  01/29/2008  ½ºÄÒ¼Á  Ç°ÁÐÏÙ¼²²¡
ANDA # 078066  CALCITRIOL¹Ç»¯Èý´¼  AKORN  Approval  01/29/2008  ×¢Éä¼Á  Î¬ÉúËØÀàÒ©
ANDA # 078242  TECHNETIUM TC-99M MEBROFENIN KITï½99¼×äå·ÆÄþÊÔ¼ÁºÐ  CIS  Approval  01/29/2008  ¡ª¡ª  Õï¶ÏÓÃÒ©
ANDA # 078850  LAMIVUDINEÀ­Ã×·ò¶¨  INVAGEN PHARMS  Tentative Approval  01/29/2008  Æ¬¼Á  ÒÒ¸Î
NDA # 020151  VENLAFAXINE HYDROCHLORIDEÑÎËáάÀ­·¨ÐÁ  WYETH PHARMS INC  Labeling Revision  01/30/2008  Æ¬¼Á  ¿¹ÒÖÓôÒ©
NDA # 020699  VENLAFAXINE HYDROCHLORIDEÑÎËáάÀ­·¨ÐÁ  WYETH PHARMS INC  Labeling Revision  01/30/2008  ½ºÄÒ¼Á£¨ER£©  ¿¹ÒÖÓôÒ©
ANDA # 040732  PHENYTOIN SODIUM±½Í×Ӣį  WOCKHARDT USA  Approval  01/30/2008  ½ºÄÒ¼Á  ¿¹ñ²ðïÒ©
ANDA # 077693  CALCIUM ACETATE´×Ëá¸Æ  ROXANE  Approval  01/30/2008  Æ¬¼Á  ÓªÑø²¹³ä¼Á
ANDA # 078075  BRIMONIDINE TARTRATE¾ÆÊ¯ËáäåĪÄᶨ  SANDOZ  Approval  01/30/2008  µÎÑÛÒº  Çà¹âÑÛ
ANDA # 078327  SUMATRIPTAN SUCCINATEÊæÂí̹çúçêËáÑΠ AUROBINDO PHARMA  Tentative Approval  01/30/2008  Æ¬¼Á  Æ«Í·Í´
ANDA # 078725  GRANISETRON HYDROCHLORIDEÑÎËá¸ñÀ­Ë¾Çí  MYLAN  Approval  01/30/2008  ×¢Éä¼Á  ¿¹Ö×ÁöÒ©
NDA # 020683  ETHINYL ESTRADIOL; LEVONORGESTRELȲ´Æ´¼×óȲŵÔÐͪ  WYETH PHARMS INC  Labeling Revision  01/31/2008  Æ¬¼Á  ±ÜÔÐÒ©
NDA # 021437  EPLERENONEÒÀÆÕÀûͪ  GD SEARLE LLC  Patient Population Altered  01/31/2008  Æ¬¼Á  ¸ßѪѹ
NDA # 021928  VARENICLINE TARTRATE¾ÆÊ¯ËáÍßÂ×Äá¿ËÁÖ  PFIZER INC  Labeling Revision  01/31/2008  Æ¬¼Á  ½äÑÌÒ©
NDA # 022064  LEVOCETIRIZINE DIHYDROCHLORIDEÑÎËá×óÐýÎ÷ÌæÀûຠ UCB INC  Labeling Revision  01/31/2008  Æ¬¼Á  ¿¹¹ýÃôÒ©
ANDA # 077260  IRINOTECAN HYDROCHLORIDEÑÎËáÒÁÁ¢Ì濵  TEVA PARENTERAL  Tentative Approval  01/31/2008  ×¢Éä¼Á  ¿¹Ö×ÁöÒ©
ANDA # 077760  PROPRANOLOL HYDROCHLORIDEÑÎËáÆÕÝÁÂå¶û  HIKMA FARMACEUTICA  Approval  01/31/2008  ×¢Éä¼Á  ¸ßѪѹ
ANDA # 078002  CAFFEINE CITRATEÄûÃÊËá¿§·ÈÒò  ABRAXIS PHARM PRODS  Approval  01/31/2008  ¿Ú·þÈÜÒº  Ð˷ܼÁ
ANDA # 078081  AMLODIPINE BESYLATE±½»ÇËá°±ÂÈµØÆ½  MUTUAL PHARMA  Approval  01/31/2008  Æ¬¼Á  ¸ßѪѹ
ANDA # 078619  FLUOXETINE HYDROCHLORIDEÑÎËá·úÎ÷Í¡  AUROBINDO PHARMA  Approval  01/31/2008  ½ºÄÒ¼Á  ¿¹ÒÖÓôÒ©
ANDA # 078626  SERTRALINE HYDROCHLORIDEÑÎËáÉáÇúÁÖ  MATRIX LABS LTD  Approval  01/31/2008  Æ¬¼Á  ¿¹ÒÖÓôÒ©
ANDA # 078787  GABAPENTIN¼Ó°ÍÅç¶¡  AUROBINDO PHARM  Approval  01/31/2008  ½ºÄÒ¼Á  ¿¹ñ²ðïÒ©

[ Last edited by xiaohezi7844 on 2008-4-3 at 21:19 ]
»Ø¸´´ËÂ¥

» ²ÂÄãϲ»¶

» ±¾Ö÷ÌâÏà¹ØÉ̼ÒÍÆ¼ö: (ÎÒÒ²ÒªÔÚÕâÀïÍÆ¹ã)

ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

xiaohezi7844

½ûÑÔ (ÖªÃû×÷¼Ò)

FDA08Äê¶þÔÂÅú×¼µÄÒ©Æ·£¨ÉÏ£©

NDA # 020564  LAMIVUDINEÀ­Ã×·ò¶¨  GLAXOSMITHKLINE  Patient Population Altered  02/01/2008  Æ¬¼Á  ÂýÒÒ¸Î
NDA # 007638  CHLORPHENIRAMINE MALEATEÂíÀ´ËáÂȱ½ÄÇÃô  SCHERING PLOUGH  Labeling Revision  02/04/2008  Æ¬¼Á£¨ER£©  ¿¹¹ýÃôÒ©
NDA # 017058  METHADONE HYDROCHLORIDEÑÎËáÃÀɳͪ  ROXANE  Labeling Revision  02/04/2008  Æ¬¼Á  ½ä¶¾Ò©
NDA # 017116  METHADONE HYDROCHLORIDEÑÎËáÃÀɳͪ  MALLINCKRODT  Labeling Revision  02/04/2008  Å¨ËõÒº  ½ä¶¾Ò©
NDA # 018063  NADOLOLÄɶàÂå¶û  KING PHARMS  Labeling Revision  02/04/2008  Æ¬¼Á  ¸ßѪѹ
NDA # 021272  TREPROSTINIL SODIUMÇúǰÁл·ËØÄÆ  UNITED THERAP  Labeling Revision  02/04/2008  ×¢Éä¼Á  ·Î¶¯Âö¸ßѹ
ANDA # 078785  ATAZANAVIR SULFATE°¢ÔúÄÇΤÁòËáÑΠ EMCURE PHARMA  Tentative Approval  02/04/2008  ½ºÄÒ¼Á  ¿¹²¡¶¾Ò©
NDA # 021140  LOPERAMIDE HYDROCHLORIDE; SIMETHICONEÑÎËáÂåßß¶¡°·/¶þ¼×»ù¹èÓÍ  MCNEIL CONS  Labeling Revision  02/05/2008  Æ¬¼Á  Ö¹ÐºÒ©
NDA # 021266  VORICONAZOLE·üÁ¢¿µßò  PFIZER  Labeling Revision  02/05/2008  Æ¬¼Á  ¿¹¾úÒ©
NDA # 021514  METHYLPHENIDATEßß¼×õ¥  SHIRE  Labeling Revision  02/05/2008  Ä¤¼Á£¨ER£©  ADHD£¨¶à¶¯£©
NDA # 021730  LEVALBUTEROL TARTRATE×óÐýɳ¶¡°·´¼¾ÆÊ¯ËáÑΠ SEPRACOR  Control Supplement  02/05/2008  ÆøÎí¼Á  Ö§Æø¹Ü¾·ÂÎ
NDA # 021881  ASCORBIC ACID; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM ASCORBATE; SODIUM CHLORIDE; SODIUM SULFATE¿¹»µÑªËá/¾ÛÒÒ¶þ´¼3350/ÂÈ»¯¼Ø/VCÄÆ/ÂÈ»¯ÄÆ/ÁòËáÄÆ  SALIX PHARMS  Labeling Revision  02/05/2008  ¿Ú·þÈÜÒº  Ç峦
            
ANDA # 065323  CEFUROXIME AXETILÍ·æßß»ÐÁõ¥  RANBAXY  Approval  02/05/2008  ¿Ú·þ»ìÐü¼Á  ¿¹ÉúËØ
ANDA # 077830  ESOMEPRAZOLE MAGNESIUM°£Ë÷ÃÀÀ­ßòþ  RANBAXY  Tentative Approval  02/05/2008  ½ºÄÒ£¨DR£©  PPI
NDA # 017577  OXYBUTYNIN CHLORIDEÑÎËá°ÂÎô²¼Äþ  ALZA  Labeling Revision  02/06/2008  Æ¬¼Á  °òë×Ñס¢ÄòµÀÑ×
NDA # 020238  CIMETIDINE¼×ëæßä°·  GLAXOSMITHKLINE  Labeling Revision  02/06/2008  Æ¬¼Á  ¿¹Î¸À£ÑñÒ©
NDA # 050006  DOXYCYCLINE¶àÎ÷»·ËØ  PFIZER  Labeling Revision  02/06/2008  »ìÐü¼Á  ¿¹ÉúËØ
NDA # 050007  DOXYCYCLINE HYCLATEÑÎËá¶àÎ÷»·ËØ  PFIZER  Labeling Revision  02/06/2008  ½ºÄÒ¼Á  ¿¹ÉúËØ
NDA # 050480  DOXYCYCLINE CALCIUM¶àÎ÷»·ËظƠ PFIZER  Labeling Revision  02/06/2008  »ìÐü¼Á  ¿¹ÉúËØ
ANDA # 074681  FLUCONAZOLE·ú¿µßò  TEVA  Facility Addition  02/06/2008  Æ¬¼Á  ¿¹¾úÒ©
ANDA # 075710  ALENDRONATE SODIUM°¢ÂØì¢ËáÄÆ  TEVA PHARMS  Approval  02/06/2008  Æ¬¼Á  ¿¹¹ÇÖÊÔöÉú
ANDA # 075960  TRAMADOL HYDROCHLORIDEÑÎËáÇúÂí¶à  ACTAVIS ELIZABETH  Control Supplement  02/06/2008  Æ¬¼Á  ÕòÍ´Ò©
ANDA # 076184  ALENDRONATE SODIUM°¢ÂØì¢ËáÄÆ  BARR  Approval  02/06/2008  Æ¬¼Á  ¿¹¹ÇÖÊÔöÉú
ANDA # 077355  CALCIUM CARBONATE; FAMOTIDINE; MAGNESIUM HYDROXIDE·¨ÄªÌæ¶¡/̼Ëá¸Æ/ÇâÑõ»¯Ã¾  PERRIGO R AND D  Approval  02/06/2008  Æ¬¼Á£¨¾×½À£©  ¿¹Î¸À£ÑñÒ©
ANDA # 077615  DIVALPROEX SODIUMË«±ûÎìËáÄÆ  NU-PHARM, INC.  Tentative Approval  02/06/2008  Æ¬¼Á£¨DR£©  ¿¹ñ²ðïÒ©
ANDA # 078031  DICLOFENAC SODIUMË«ÂÈ·ÒËáÄÆ  ALCON  Approval  02/06/2008  µÎÑÛ¼Á  NSAID
ANDA # 078290  DIVALPROEX SODIUMË«±ûÎìËáÄÆ  SANDOZ  Tentative Approval  02/06/2008  Æ¬¼Á£¨DR£©  ¿¹ñ²ðïÒ©
NDA # 019813  FENTANYL·ÒÌ«Äá  ALZA  Labeling Revision  02/07/2008  Ä¤¼Á£¨ER£©  ÕòÍ´Ò©
NDA # 020151  VENLAFAXINE HYDROCHLORIDEÑÎËáÎÄÀ­·¨ÐÁ  WYETH PHARMS INC  Labeling Revision  02/07/2008  Æ¬¼Á  ÒÖÓôÖ¢
NDA # 021445  EZETIMIBEÒÀÔóÌæÃ×±´  MSP SINGAPORE  Labeling Revision  02/07/2008  Æ¬¼Á  ½µÖ¬Ò©
NDA # 021947  FENTANYL CITRATEÄûÃÊËá·ÒÌ«Äá  CEPHALON  Labeling Revision  02/07/2008  Æ¬¼Á  ÕòÍ´Ò©
NDA # 050582  DOXYCYCLINE HYCLATEÑÎËá¶àÎ÷»·ËØ  MAYNE PHARMA INTL  Labeling Revision  02/07/2008  ½ºÄÒ¼Á£¨DR£©  ¿¹ÉúËØ
ANDA # 077800  LEVALBUTEROL HYDROCHLORIDEÑÎËá×óÐýɳ¶¡°·´¼  DEY LP  Tentative Approval  02/07/2008  ÈÜÒº¼Á  Ö§Æø¹Ü¾·ÂÎ
NDA # 020941  DOCOSANOL¶þÊ®¶þÍé´¼   GLAXOSMITHKLINE  Manufacturing Change or Addition  02/08/2008  Èé¸à  ¿Ú¡¢Á³²¿ðåÕî
NDA # 021210  LEVOTHYROXINE SODIUM¼××´ÏÙËØÄÆ  STEVENS J  Formulation Revision  02/08/2008  Æ¬¼Á  ¼××´ÏÙ¹¦ÄܼõÍËÖ¢
NDA # 021518  SOLIFENACIN SUCCINATEË÷·ÇÄÇÐÁ  ASTELLAS  Labeling Revision  02/08/2008  Æ¬¼Á  °òë׶ද֢
NDA # 021687  EZETIMIBE; SIMVASTATINÒÀÔóÌæÃ×±´/ÐÁ·¥ËûÍ¡  MSP SINGAPORE  Labeling Revision  02/08/2008  Æ¬¼Á  ½µÖ¬Ò©
ANDA # 040613  HOMATROPINE METHYLBROMIDE/HYDROCODONE BITARTRATEÖØ¾ÆÊ¯Ëá¶þÇâ¿É´ýÒòͪ/äå¼×ºóÂíÍÐÆ·  HI TECH PHARMA  Approval  02/08/2008  Ìǽ¬¼Á  Âé×íÒ©
NDA # 013055  ORPHENADRINE CITRATEèÛéÚËá°Â·ÒÄǾý   GRACEWAY  Labeling Revision  02/11/2008  ×¢Éä¼Á  Âé×íÒ©/½â¾·Ò©
NDA # 020151  VENLAFAXINE HYDROCHLORIDEÑÎËáÎÄÀ­·¨ÐÁ  WYETH PHARMS INC  Labeling Revision  02/11/2008  ½ºÄÒ£¨»ºÊÍ£©  ÒÖÓôÖ¢
ANDA # 065302  AZITHROMYCIN°¢ÆæÃ¹ËØ  WOCKHARDT  Approval  02/11/2008  Æ¬¼Á  ¿¹ÉúËØ
ANDA # 077491  PRAVASTATIN SODIUMÆÕ·¥ËûÍ¡ÄÆ  LEK PHARMS DD  Approval  02/11/2008  Æ¬¼Á  ½µÖ¬Ò©
ANDA # 077821  ACETAMINOPHEN; PROPOXYPHENE NAPSYLATEÎÞË®ÝÁ»ÇËáÓÒ±ûÑõ·Ò¡¢¶ÔÒÒõ£°±»ù·Ó  CONCORD LABS NJ  Approval  02/11/2008  Æ¬¼Á  ÕòÍ´Ò©
ANDA # 078371  FINASTERIDE·ÇÄÇÐÛ°·  ACTAVIS TOTOWA  Approval  02/11/2008  Æ¬¼Á  Ç°ÁÐÏÙÔöÉú
ANDA # 078391  HYDROCHLOROTHIAZIDEÇâÂÈàçຠ CADISTA PHARMS  Approval  02/11/2008  ½ºÄÒ¼Á  ÀûÄò¼Á
ANDA # 078575  BICALUTAMIDE±È¿¨Â³°·  SANDOZ  Tentative Approval  02/11/2008  Æ¬¼Á  Ç°ÁÐÏÙ°©
ANDA # 078597  DIVALPROEX SODIUMË«±ûÎìËáÄÆ  SUN PHARM INDS LTD  Tentative Approval  02/11/2008  Æ¬¼Á£¨DR£©  ¿¹ñ²ðïÒ©
NDA # 017892  TRIAZOLAMÈýßòÂØ  PHARMACIA AND UPJOHN  Labeling Revision  02/12/2008  Æ¬¼Á  ´ßÃß¼Á
ANDA # 040717  PRIMIDONEÆËÃ×ͪ  IMPAX LABS  Approval  02/12/2008  Æ¬¼Á  ¿¹ñ²ðïÒ©
ANDA # 040724  PROMETHAZINE HYDROCHLORIDEÑÎËáÒì±ûຠ IMPAX LABS  Approval  02/12/2008  Æ¬¼Á  ¿¹¹ýÃôÒ©
NDA # 020778  NELFINAVIR MESYLATE¼×»ÇÄηÇÄÇΤ  AGOURON  Labeling Revision  02/13/2008  ·ÛÄ©¼Á  ¿¹°¬×ÌÒ©
NDA # 021336  SELEGILINE˾À´¼ªÀ¼  SOMERSET  Labeling Revision  02/13/2008  Ä¤¼Á£¨ER£©  ÅÁ½ðÉ­Ö¢
ANDA # 078408  VINORELBINE TARTRATE ¾ÆÊ¯Ë᳤´ºÈð±õ  EBEWE PHARMA  Approval  02/13/2008  ×¢Éä¼Á  ¿¹Ö×ÁöÒ©
ANDA # 078678  GRANISETRON HYDROCHLORIDEÑÎËá¸ñÀ­Ë¾Çí  ORCHID HLTHCARE  Approval  02/13/2008  Æ¬¼Á  »¯ÁÆÖ¹ÍÂÒ©
NDA # 020683  ETHINYL ESTRADIOL; LEVONORGESTREL×óȲŵÔÐͪ/Ȳ´Æ´¼  WYETH PHARMS INC  Labeling Revision  02/14/2008  Æ¬¼Á  ±ÜÔÐÒ©
NDA # 022081  AMBRISENTAN°²²©É­Ì¹  GILEAD  Labeling Revision  02/14/2008  Æ¬¼Á  ·Î¶¯Âö¸ßѹ
ANDA # 040699  BENZTROPINE MESYLATE¼×»ÇËá±½ÔúÍÐÆ·  ACTAVIS TOTOWA  Approval  02/14/2008  Æ¬¼Á  ÅÁ½ðÉ­Ö¢
ANDA # 078191  RAMIPRILÀ×ÃׯÕÀû  DR REDDYS LABS LTD  Tentative Approval  02/14/2008  ½ºÄÒ¼Á  ¸ßѪѹ
ANDA # 078409  LAMOTRIGINEÀ­ÄªÈýຠ SANDOZ  Tentative Approval  02/14/2008  Æ¬¼Á  ¿¹ñ²ðïÒ©
ANDA # 078692  CETIRIZINE HYDROCHLORIDEÑÎËáÎ÷ÌæÀûຠ SANDOZ  Approval  02/14/2008  ¾×½ÀƬ¼Á  ¿¹¹ýÃôÒ©
ANDA # 078922  ZIDOVUDINEÆë¶à·ò¶¨  MATRIX LABS LTD  Approval  02/14/2008  Æ¬¼Á  ÒÒ¸Î
NDA # 019962  METOPROLOL SUCCINATEçúçêËáÃÀÍÐÂå¶û  ASTRAZENECA  Control Supplement  02/15/2008  Æ¬¼Á£¨ER£©  ¸ßѪѹ
NDA # 021277  MOXIFLOXACIN HYDROCHLORIDEÑÎËáĪÎ÷ɳÐÇ  BAYER PHARMS  Labeling Revision  02/15/2008  Æ¬¼Á  ¿¹ÉúËØ
NDA # 021085  MOXIFLOXACIN HYDROCHLORIDEÑÎËáĪÎ÷ɳÐÇ  BAYER PHARMS  Labeling Revision  02/15/2008  ×¢Éä¼Á  ¿¹ÉúËØ
NDA # 021937  EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATEÒÀ·¨Î¤ÂØ/¶÷ÇúËû±õ/ÌæÅµ¸£Î¤õ¥  GILEAD  Labeling Revision  02/15/2008  Æ¬¼Á  ¿¹°¬×ÌÒ©
NDA # 021985  ALISKIREN HEMIFUMARATE¸»ÂíËá°¢Àû¿ËÂØ  NOVARTIS  Labeling Revision  02/15/2008  Æ¬¼Á  ¸ßѪѹ
NDA # 022078  NIACIN/SIMVASTATINÑÌËáÐÁ·¥ËûÍ¡  ABBOTT  Approval  02/15/2008  Æ¬¼Á  ½µÖ¬Ò©
NDA # 050781  MINOCYCLINE HYDROCHLORIDEÑÎËáÃ×ŵ»·ËØ  ORAPHARMA  Labeling Revision  02/15/2008  ·Û¼Á£¨ER£©  ¿¹ÉúËØ
ANDA # 065359  CEFUROXIME AXETILÍ·æßß»ÐÁõ¥  ORCHID HLTHCARE  Approval  02/15/2008  Æ¬¼Á  ¿¹ÉúËØ
ANDA # 078688  BENDROFLUMETHIAZIDE; NADOLOLÜзúàçàº/ÄɶàÂå¶û  MYLAN  Approval  02/15/2008  Æ¬¼Á  ¸ßѪѹ
FDA08Äê¶þÔÂÅú×¼µÄÒ©Æ·£¨Ï£©

(ANDA # 077724)   PRAMIPEXOLE DIHYDROCHLORIDEÑÎËáÆÕÀ­¿ËË÷  BARR  Approval  02/19/2008Ƭ¼Á/ÅÁ½ðÉ­Ö¢      
(NDA # 021548)FOSAMPRENAVIR CALCIUM¸£Ë¾°²ÆÕÄÇΤ¸Æ  GLAXOSMITHKLINE  Labeling Revision  02/20/2008/Ƭ¼Á/¿¹°¬×ÌÒ©
(NDA # 021567)ATAZANAVIR SULFATE°¢ÔúÄÇΤÁòËáÑΠ BRISTOL MYERS SQUIBB  Labeling Revision  02/20/2008½ºÄÒ/¿¹°¬×ÌÒ©
(NDA # 021692) TRAMADOL HYDROCHLORIDEÑÎËáÇúÂí¶à  BIOVAIL LABS INTL  Labeling Revision  02/20/2008Ƭ¼Á£¨ER£©/ÕòÍ´Ò©   
(NDA # 022029)METHYL SALICYATE/MENTHOLË®ÑîËá¼×õ¥/±¡ºÉÄÔ  HISAMITSU PHARM  Approval  02/20/2008Ìù¼Á/ֹʹҩ   
(ANDA # 077219)IRINOTECAN HYDROCHLORIDEÑÎËáÒÁÁ¢Ì濵  WATSON LABS  Approval  02/20/2008×¢Éä¼Á/¿¹Ö×ÁöÒ©   
(NDA # 016199) HYDROCORTISONEÇ⻯¿ÉµÄËÉ  ANI PHARMS  Labeling Revision  02/21/2008¹à³¦¼Á/À£ÑñÐԽ᳦Ñ×
2Â¥2008-04-03 16:23:40
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

xiaohezi7844

½ûÑÔ (ÖªÃû×÷¼Ò)

(NDA # 018771)HYDROXYPROPYL CELLULOSEôDZû»ùÏËÎ¬ËØ  ATON  Labeling Revision  02/21/2008ÑÛ²¿²åÈë¼Á/¸ÉÑÛ×ÛºÏÖ¢   
(NDA # 021036) ZANAMIVIRÔúÄÇÃ×Τ  GLAXOSMITHKLINE  Labeling Revision  02/21/2008·Û¼Á/¿¹²¡¶¾Ò©        
(NDA # 022028) COSYNTROPINÌæ¿É¿ËëÄ  SANDOZ  Approval  02/21/2008×¢Éä¼Á/´ÙƤÖÊËØÀàÒ©        
(NDA # 050441) CLINDAMYCIN PHOSPHATE¿ËÁÖÃ¹ËØÁ×Ëáõ¥  PHARMACIA AND UPJOHN  Labeling Revision  02/21/2008/×¢Éä¼Á/¿¹ÉúËØ   
(NDA # 050536)ERYTHROMYCINºìÃ¹ËØ  HOSPIRA  Labeling Revision  02/21/2008½ºÄÒ£¨DR£©¿¹ÉúËØ        
(NDA # 050547)CEFOTAXIME SODIUMÍ·æßàçë¿ÄÆ  SANOFI AVENTIS US  Labeling Revision  02/21/2008×¢Éä¼Á/¿¹ÉúËØ        
(ANDA # 065396)CEFADROXIL/CEFADROXIL HEMIHYDRATEÍ·æßôǰ±ÜÐ/°ëˮͷæßôǰ±ÜР LUPIN  Approval  02/21/2008»ìÐü¼Á/¿¹ÉúËØ   
(ANDA # 078024) CIPROFLOXACIN; DEXTROSE»·±ûɳÐÇ/ÆÏÌÑÌÇ  CLARIS LIFESCIENCES  Tentative Approval  02/21/2008×¢Éä¼Á/¿¹ÉúËØ   
(BLA # 125057) ADALIMUMAB°¢´ïľµ¥¿¹  ABBOTT  Supplement  02/21/2008×¢Éä¼Á/¹Ø½ÚÑ×        
(NDA # 021071) ROSIGLITAZONE MALEATEÂíÀ´ËáÂÞ¸ñÁÐͪ  SB PHARMCO  Labeling Revision  02/22/2008Ƭ¼Á/½µÌÇÒ©   
(NDA # 050794) AZACITIDINE°¢Ôú°ûÜÕ  PHARMION  Manufacturing Change or Addition  02/22/2008×¢Éä¼Á/¹ÇËèÔöÉúÒì³£×ÛºÏÕ÷      
(BLA # 125085)BEVACIZUMAB±´·¥µ¥¿¹  GENENTECH  Supplement  02/22/2008×¢Éä¼Á/¿¹Ö×ÁöÒ©        
(NDA # 018163) TEMAZEPAMÌæÂíÎ÷ãú  TYCO HLTHCARE  Labeling Revision  02/25/2008½ºÄÒ¼Á/´ßÃßÒ©        
(NDA # 020895)SILDENAFIL CITRATEÎ÷µØÄÇ·ÇÄûÃÊËáÑΠ PFIZER IRELAND  Labeling Revision  02/25/2008Ƭ¼Á/¿¹EDÒ©   
(NDA # 021976) DARUNAVIR ETHANOLATEµØÈðÄÇΤ  TIBOTEC  Formulation Revision  02/25/2008Ƭ¼Á/¿¹°¬×ÌÒ©        
(ANDA # 077170)CERTIRIZINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDEÑÎËáÎ÷ÌæÀûàº/ÑÎËáαÂ黯¼î  TEVA PHARMS  Approval  02/25/2008Ƭ¼Á£¨ER£©¹ýÃôÐÔ±ÇÑ×        
(ANDA # 077234)AMIODARONE HYDROCHLORIDEÑÎËá°·µâͪ  HIKMA FARMACEUTICA  Approval  02/25/2008×¢Éä¼Á/¿¹ÐÄÂÉʧ³£Ò©   
(NDA # 021067) MOMETASONE FUROATE¿·ËáĪÃ×ËÉ  SCHERING  Labeling Revision  02/26/2008·Û¼Á/ƤÖʼ¤ËØ        
(NDA # 021813)ESTRADIOL´Æ¶þ´¼   BRADLEY PHARMS  Package Change  02/26/2008Äý½º¼Á/´Æ¼¤ËØ        
(NDA # 022044) METFORMIN HYDROCHLORIDE; SITAGLIPTIN PHOSPHATEÁ×ËáÎ÷ËûÁÐÍ¡/ÑÎËá¶þ¼×Ë«ëÒ  MERCK  Efficacy Supplement with Clinical Data to Support  02/26/2008Ƭ¼Á/½µÌÇÒ©        
(NDA # 022057) PROGESTERONE»ÆÌåͪ  FERRING  Labeling Revision  02/26/2008Äý½º¼Á/Ôм¤ËØ        
(ANDA # 040814)CARBINOXAMINE MALEATEÂíÀ´ËῨ±ÈɳÃ÷  BOCA PHARMA  Approval  02/26/2008¿Ú·þÈÜÒº/¿¹¹ýÃôÒ©      
(NDA # 050609) ERYTHROMYCIN LACTOBIONATEÈéÌÇËáºìÃ¹ËØ  HOSPIRA  Labeling Revision  02/26/2008×¢Éä¼Á/¿¹ÉúËØ        
(NDA # 050742) IVERMECTINÒÁά¾úËØ  MERCK  Manufacturing Change or Addition  02/26/2008Ƭ¼Á/¿¹ÉúËØ        
(ANDA # 077728)CALCIUM ACETATE´×Ëá¸Æ  ROXANE  Approval  02/26/2008½ºÄÒ/ÓªÑø²¹³ä¼Á        
(ANDA # 078058)ANASTROZOLE°¢ÄÇÇúßò  TEVA PHARMS  Tentative Approval  02/26/2008Ƭ¼Á/¿¹Ö×ÁöÒ©        
(ANDA # 078098) TECHNETIUM TC-99M SESTAMIBIï½TC-99M˾Ëû±È   MALLINCKRODT  Tentative Approval  02/26/2008×¢Éä¼Á/Õï¶ÏÊÔ¼Á  
(ANDA # 078155) SIMVASTATINÐÁ·¥ËûÍ¡  ACCORD HLTHCARE  Approval  02/26/2008Ƭ¼Á/½µÖ¬Ò©        
(ANDA # 078478)TORSEMIDEÍÐÀ­ÈûÃ×  SUN PHARM INDS  Approval  02/26/2008Ƭ¼Á/ÀûÄò¼Á        
(NDA # 021729) ARIPIPRAZOLE°¢Á¢ßßßò  OTSUKA  Patient Population Altered  02/27/2008×¢Éä¼Á/¾«Éñ·ÖÁÑÖ¢        
(NDA # 022101)ESOMEPRAZOLE MAGNESIUM°£Ë÷ÃÀÀ­ßò  ASTRAZENECA  Approval  02/27/2008»ìÐü¼Á/ppi      
(ANDA # 040797) MEPROBAMATE¼×±û°±õ¥  INVAGEN PHARMS  Approval  02/27/2008Ƭ¼Á/¿¹½¹ÂÇÒ©        
(NDA # 050317) LINCOMYCIN HYDROCHLORIDEÑÎËáÁÖ¿ÉÃ¹ËØ  PHARMACIA AND UPJOHN  Labeling Revision  02/27/2008×¢Éä¼Á/¿¹ÉúËØ
(NDA # 050435) CARBENICILLIN INDANYL SODIUMÜÐÜáÎ÷ÁÖÄÆ   PFIZER  Labeling Revision  02/27/2008Ƭ¼Á/¿¹ÉúËØ        
(ANDA # 065425)DEMECLOCYCLINE HYDROCHLORIDEÑÎËáÈ¥¼×½ðÃ¹ËØ  AMNEAL PHARM  Approval  02/27/2008Ƭ¼Á/¿¹ÉúËØ   
(ANDA # 077260)IRINOTECAN HYDROCHLORIDEÑÎËáÒÁÁ¢Ì濵  TEVA PARENTERAL  Approval  02/27/2008×¢Éä¼Á/¿¹Ö×ÁöÒ©   
(ANDA # 077776)IRINOTECAN HYDROCHLORIDEÑÎËáÒÁÁ¢Ì濵  APP PHARMS  Approval  02/27/2008×¢Éä¼Á/¿¹Ö×ÁöÒ©   
(ANDA # 077994)IRINOTECAN HYDROCHLORIDEÑÎËáÒÁÁ¢Ì濵  SANDOZ  Approval  02/27/2008×¢Éä¼Á/¿¹Ö×ÁöÒ©        
(ANDA # 078037) GRANISETRON HYDROCHLORIDEÑÎËá¸ñÀ­Ë¾Çí  CIPLA LIMITED  Approval  02/27/2008Ƭ¼Á/¿¹Ö×ÁöÒ©   
(ANDA # 078188) IRINOTECAN HYDROCHLORIDEÑÎËáÒÁÁ¢Ì濵  DABUR ONCOLOGY PLC  Approval  02/27/2008×¢Éä¼Á/¿¹Ö×ÁöÒ©   
(ANDA # 078224) AMLODIPINE BESYLATE±½»ÇËá°±ÂÈµØÆ½  MATRIX LABS  Approval  02/27/2008Ƭ¼Á/¸ßѪѹ   
(ANDA # 078589)IRINOTECAN HYDROCHLORIDEÑÎËáÒÁÁ¢Ì濵  ACTAVIS TOTOWA  Approval  02/27/2008×¢Éä¼Á/¿¹Ö×ÁöÒ©   
(ANDA # 078745)RAMIPRILÀ×ÃׯÕÀû  INVAGEN PHARMS  Tentative Approval  02/27/2008½ºÄÒ/¸ßѪѹ        
(ANDA # 078796)IRINOTECAN HYDROCHLORIDEÑÎËáÒÁÁ¢Ì濵  HOSPIRA  Approval  02/27/2008×¢Éä¼Á/¿¹Ö×ÁöÒ©        
(ANDA # 078843)GRANISETRON HYDROCHLORIDEÑÎËá¸ñÀ­Ë¾Çí  APOTEX INC  Approval  02/27/2008Ƭ¼Á/Ö¹ÍÂÒ©
(NDA # 019872) ACETAMINOPHEN¶ÔÒÒõ£°±»ù·Ó  MCNEIL CONS  Labeling Revision  02/28/2008Ƭ¼Á£¨ER£©½âÈÈÕòÍ´Ò©
(NDA # 021318) TERIPARATIDE RECOMBINANT HUMANÈËÖØ×éÌØÁ¢ÅÁëÄ  LILLY  Labeling Revision  02/28/2008×¢Éä¼Á/¹ÇÖÊÊèËÉ
(NDA # 021688) CINACALCET HYDROCHLORIDEÑÎËáÎ÷ÄÇ¿¨Èû  AMGEN  Labeling Revision  02/28/2008Ƭ¼Á/¼××´ÅÔÏÙ»úÄÜ¿º½øºÍ¸ß¸ÆÑªÖ¢  
(NDA # 021937) EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATEÒÀ·¢Î¤ÂØ+¶÷ÇúËû±õ+ÌæÅµ¸£Î¤õ¥  GILEAD  Labeling Revision  02/28/2008Ƭ¼Á/¿¹°¬×ÌÒ©
(NDA # 022033) FLUVOXAMINE MALEATEÂíÀ´Ëá·ú·üɳÃ÷  SOLVAY PHARMS  Approval  02/28/2008Ƭ¼Á£¨ER£©/¿¹ÒÖÓôÒ©
(ANDA # 040751) IMIPRAMINE HYDROCHLORIDEÑÎËá±ûßäຠ ACTAVIS TOTOWA  Approval  02/28/2008Ƭ¼Á/¿¹ÒÖÓôÒ©
(ANDA # 078334) GRANISETRON HYDROCHLORIDEÑÎËá¸ñÀ­Ë¾Çí  CYPRESS PHARM  Approval  02/28/2008¿Ú·þÈÜÒº/Ö¹ÍÂÒ©
(ANDA # 078957) STAVUDINE˾Ëû·ò¶¨   INVAGEN PHARMS  Tentative Approval  02/28/2008½ºÄÒ/¿¹°¬×ÌÒ©
(NDA # 010402)ESTROGENS, CONJUGATED¹²éî´Æ¼¤ËØ  WYETH PHARMS INC  Labeling Revision  02/29/2008×¢Éä¼Á/´Æ¼¤ËØÈ±·¦Ö¢
(NDA # 020591) TRANDOLAPRIL; VERAPAMIL HYDROCHLORIDEȺ¶àÆÕÀû/άÀ­ÅÁÃ×  ABBOTT  Labeling Revision  02/29/2008Ƭ¼Á£¨ER£©/¸ßѪѹ
(NDA # 021229)OMEPRAZOLE MAGNESIUM°ÂÃÀÀ­ßòþ  ASTRAZENECA  Package Change  02/29/2008Ƭ¼Á£¨DR£©/PPI   
(NDA # 021305) SODIUM IODIDE, I-131µâ»¯ÄÆ  DRAXIMAGE  Labeling Revision  02/29/2008½ºÄÒ/Õï¶ÏÊÔ¼Á   
(NDA # 021348) MIGLUSTATÃÀ¸ñÂ³ÌØ  ACTELION PHARMS  Labeling Revision  02/29/2008½ºÄÒ/Gaucher²¡        
(NDA # 021372) PALONOSETRON HYDROCHLORIDEÑÎËáÅÁÂåŵ˾Çí  HELSINN HLTHCARE  Efficacy Supplement with Clinical Data to Support  02/29/2008×¢Éä¼Á/Ö¹ÍÂÒ©
(NDA # 021610) OXYMORPHONE HYDROCHLORIDEÑÎËáôÇÂð·Èͪ  ENDO PHARMS Manufacturing Change or Addition  02/29/2008Ƭ¼Á£¨ER£©/ÕòÍ´Ò©  
£¨NDA # 021992) DESVENLAFAXINE SUCCINATEçúçêËáÈ¥¼×ÎÄÀ­·¨ÐÁ  WYETH PHARMS INC  Approval  02/29/2008Ƭ¼Á£¨ER£©/¿¹ÒÖÓôÖ¢
(NDA # 022118)FENOFIBRATE·Çŵ±´ÌØ  LIFECYCLE PHARMA AS  Labeling Revision  02/29/2008Ƭ¼Á/½µÖ¬Ò©   
(ANDA # 078381) AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE±½»ÇËá°±ÂÈµØÆ½/ÑÎËá±´ÄÇÆÕÀû  KALI LABS  Tentative Approval  02/29/2008½ºÄÒ/¸ßѪѹ
(ANDA # 078566) GRANISETRON HYDROCHLORIDEÑÎËá¸ñÀ­Ë¹Çí  WOCKHARDT USA  Approval  02/29/2008×¢Éä¼Á/Ö¹ÍÂÒ©      
(ANDA # 078886) EFAVIRENZÒÀ·¨Î¤¶÷´Ä  INVAGEN PHARMS  Tentative Approval  02/29/2008Ƭ¼Á/¿¹°¬×ÌÒ©
08ÄêÈýÔÂÅú×¼µÄÒ©Æ·£¨ÉÏ£©

(NDA # 050638)   PENICILLIN G POTASSIUMÇàÃ¹ËØ¼Ø  BAXTER HLTHCARE  Labeling Revision  03/01/2008/×¢Éä¼Á/¿¹ÉúËØ   
(NDA # 004782) ESTROGENS, CONJUGATED¹²éî´Æ¼¤ËØ WYETH PHARMS INC  Labeling Revision  03/03/2008/Ƭ¼Á/´Æ¼¤ËØÈ±·¦Ö¢
(NDA # 020527) ESTROGENS, CONJUGATED; MEDROXYPROGESTERONE ACETATE¹²éî´Æ¼¤ËØ£»´×Ëá¼×ôÇÔÐͪ  WYETH PHARMS INC  Labeling Revision  03/03/2008/Ƭ¼Á/´Æ¼¤ËØÈ±·¦Ö¢
(NDA # 021008)   OCTREOTIDE ACETATE´×Ëá°ÂÇúëÄ NOVARTIS  New or Modified Indication  03/03/2008/×¢Éä¼Á/Ö«¶Ë·Ê´óÖ¢/¿¹Ö×ÁöÒ©
£¨ANDA # 078313)   ESCITALOPRAM OXALATE²ÝËás-Î÷̪ÆÕÀ¼  WATSON LABS  Tentative Approval  03/03/2008/Ƭ¼Á/ÒÖÓôÖ¢
(ANDA # 078639)   FOMEPIZOLE¼×ßÁßò  SYNERX PHARMA  Approval  03/03/2008/×¢Éä¼Á/½â¶¾¼Á
(ANDA # 078710)   TELMISARTANÌæÃ×ɳ̹  WATSON LABS  Tentative Approval  03/03/2008/Ƭ¼Á/¸ßѪѹ
(NDA # 021779)   ILOPROSTÒÀŵǰÁл·ËØ  ACTELION PHARM  Labeling Revision  03/04/2008/ÈÜÒº¼Á/·Î¶¯Âö¸ßѹ
(ANDA # 077329)   OCTREOTIDE ACETATE´×Ëá°ÂÇúëÄ  SUN PHARM INDS  Approval  03/04/2008/×¢Éä¼Á/Ö«¶Ë·Ê´óÖ¢/¿¹Ö×ÁöÒ©
(ANDA # 077982)   ALENDRONATE SODIUM°¢ÂØì¢ËáÄÆ  APOTEX  Tentative Approval  03/04/2008/Ƭ¼Á/¹ÇÖÊÊèËÉ
(ANDA # 078433)   GEMCITABINE HYDROCHLORIDÑÎËáE¼ªÎ÷Ëû±ö  SUN PHARM INDS  Tentative Approval  03/04/2008×¢Éä¼Á/¿¹Ö×Áö
(NDA # 021083)   SIROLIMUSÎ÷ÂÞĪ˾  WYETH PHARMS INC  Labeling Revision  03/05/2008/¿Ú·þÈÜÒº/ÃâÒßÒÖÖÆ¼Á
(NDA # 021548)   FOSAMPRENAVIR CALCIUM¸£É³ÄÇΤ¸Æ   GLAXOSMITHKLINE  Labeling Revision  03/05/2008/Ƭ¼Á/¿¹AIDS
(NDA # 022116)   FOSAMPRENAVIR CALCIUM¸£É³ÄÇΤ¸Æ   GLAXO  Labeling Revision  03/05/2008/»ìÐüÒº/¿¹AIDS
(ANDA # 040673)   PROMETHAZINE HYDROCHLORIDEÑÎËáÒì±ûຠ ACTAVIS TOTOWA  Approval  03/05/2008/Ƭ¼Á/¿¹¹ýÃôÒ©
(ANDA # 077991)   CETIRIZINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDEÑÎËáÎ÷ÌæÀûຣ»ÑÎËáαÂ黯¼î SANDOZ Approval 03/05/2008/Ƭ¼ÁER/¿¹¸Ððҩ
(ANDA # 078276)   OLMESARTAN MEDOXOMIL°ÂÃÀɳ̹õ¥  MYLAN PHARMA  Tentative Approval  03/05/2008/Ƭ¼Á/½µÑ¹Ò©
(NDA # 015034)   MEFENAMIC ACID¼×·ÒÄÇËá  SCIELE PHARMA INC  Labeling Revision  03/06/2008/½ºÄÒ/NSAIDs
(NDA # 020990)   SERTRALINE HYDROCHLORIDEÑÎËáÉáÇúÁÖ  PFIZER  Labeling Revision  03/06/2008/Ƭ¼Á/ÒÖÓôÖ¢
(NDA # 021299)   PAROXETINE MESYLATE¼×»ÇËáÅÁÂÞÎ÷Í¡  JDS PHARMS  Labeling Revision  03/06/2008/Ƭ¼Á/ÒÖÓôÖ¢
(NDA # 021436)   ARIPIPRAZOLE°¢Á¢ÅÉßò  OTSUKA  Labeling Revision  03/06/2008/Ƭ¼Á/¾«Éñ·ÖÁÑÖ¢
(ANDA # 078537)   FOMEPIZOLE¼×ßÁßò  NAVINTA LLC  Approval  03/06/2008/×¢Éä¼Á/½â¶¾¼Á
(NDA # 020140)   LEVOLEUCOVORIN×óÑÇÒ¶Ëá  SPECTRUM PHARMS  Approval  03/07/2008/×¢Éä¼Á/¿¹Ö×Áö
(NDA # 020829)   MONTELUKAST SODIUMÃÏÂ³Ë¾ÌØÄÆ  MERCK  Labeling Revision  03/07/2008/Ƭ¼Á/¿¹Ïø´­Ò©
(NDA # 021976)   DARUNAVIR ETHANOLATEµØÈðÄÇΤ  TIBOTEC  Labeling Revision  03/07/2008/Ƭ¼Á/¿¹AIDS
(ANDA # 078465)   PREDNISOLONE SODIUM PHOSPHATEÆÃÄáËÉÁúÁ×ËáÄÆ  PHARM ASSOC  Approval  03/07/2008/ÈÜÒº¼Á/¿¹Ñ×Ò©
(ANDA # 078671)   NABUMETONEÝÁ¶¡ÃÀͪ  INVAGEN PHARMS  Approval  03/07/2008/Ƭ¼Á/NSAIDs
(BLA # 103234)   EPOETIN ALFA°¢·¨ÒÀ²´Í¡   AMGEN  Supplement  03/07/2008/×¢Éä¼Á/ƶѪ
(BLA # 103951)   DARBEPOETIN ALFA°¢·¨´ï±´²´Í¡  AMGEN  Supplement  03/07/2008/×¢Éä¼Á/ƶѪ  
(NDA # 018936)   FLUOXETINE HYDROCHLORIDEÑÎËá·úÎ÷Í¡  LILLY  Labeling Revision  03/09/2008/½ºÄÒ¼Á/ÒÖÓôÖ¢
(NDA # 020675)   URSODIOLÐÜÈ¥Ñõµ¨Ëá  AXCAN SCANDIPHARM  Package Change  03/10/2008/Ƭ¼Á/µ¨½áʯ
(NDA # 021266)   VORICONAZOLE·üÁ¢¿µßò  PFIZER  Labeling Revision  03/10/2008/»ìÐü¼Á/¿¹¾úÒ©
(ANDA # 077763)   CLOBETASOL PROPIONATE¶þ±ûËáÂȱ¶ËûÃ×ËÉ  PERRIGO ISRAEL  Approval  03/10/2008/ÅçÎí¼Á/¿¹Ñ×Ò©
(ANDA # 078695)   ROSIGLITAZONE MALEATEÂíÀ´ËáÂÞ¸ñÁÐͪ  ROXANE  Tentative Approval  03/10/2008/Ƭ¼Á/½µÌÇÒ©
(NDA # 016151)   METHENAMINE HIPPURATEÂíÄòËáÎÚÂåÍÐÆ·  VATRING PHARMS  Labeling Revision  03/11/2008/Ƭ¼Á/¿¹¾úÒ©
(NDA # 018452)   SULFAMETHOXAZOLE; TRIMETHOPRIM»Ç°·¼×»ùÒì¶ñßò  MONARCH PHARMS  Labeling Revision  03/11/2008/×¢Éä¼Á/¿¹ÉúËØ
(NDA # 019111)   CHLORPHENIRAMINE POLISTIREX; HYDROCODONE POLISTIREXÂȱ½ÄÇÃô-»Ç»¯¶þÒÒÏ©±½-ÒÒÏ©±½¹²¾ÛÎ¶þÇâ¿É´ýÒòͪ-»Ç»¯¶þÒÒÏ©±½-ÒÒÏ©±½¹²¾ÛÎï  UCB INC  Labeling Revision  03/11/2008/»ìÐü¼ÁER/¿¹¸Ððҩ(NDA # 050717) FOSFOMYCIN TROMETHAMINEÁ×Ã¹ËØ»ºÑªËá°·  ZAMBON  Labeling Revision  03/11/2008/»ìÐü¼Á/¿¹¾úÒ©
(ANDA # 065407)   TOBRAMYCIN SULFATEÁòËáÍײ¼Ã¹ËØ  AKORN STRIDES  Approval  03/11/2008/×¢Éä¼Á/¿¹ÉúËØ
(ANDA # 065470)   MINOCYCLINE HYDROCHLORIDEÑÎËáÃ×ŵ»·ËØ  AUROBINDO PHARMA  Approval  03/11/2008/½ºÄÒ/¿¹ÉúËØ
(NDA # 017111)   MOLINDONE HYDROCHLORIDEÑÎËáÂðÜáͪ  ENDO PHARMS  Labeling Revision  03/12/2008/½ºÄÒ/¾«Éñ·ÖÁÑÖ¢
(NDA # 020444)   EPOPROSTENOL SODIUMÒÀǰÁд¼ÄÆ   GLAXOSMITHKLINE  Labeling Revision  03/12/2008/×¢Éä¼Á/·Î¶¯Âö¸ßѹ
(ANDA # 040812)   HYDROXYZINEôÇຠ INVAGEN PHARMS  Approval  03/12/2008/Ƭ¼Á/¿¹½¹ÂÇÒ©
(ANDA # 075982)   TRAMADOL HYDROCHLORIDEÑÎËáÇúÂí¶à  PLIVA  Control Supplement  03/12/2008/Ƭ¼Á/ÕòÍ´Ò©
(ANDA # 077413)   PACLITAXEL×Ïɼ´¼  PLIVA LACHEMA  Approval  03/12/2008/×¢Éä¼Á/¿¹Ö×ÁöÒ©  
(ANDA # 077455)   BUPROPION HYDROCHLORIDEÑÎËá°²·ÇËûͪ  ACTAVIS  Approval  03/12/2008/Ƭ¼ÁER/¿¹ÒÖÓôÒ©
(NDA # 018117)   TRIAMCINOLONE ACETONIDE´×ËáÇú°²Äε  ABBOTT  Labeling Revision  03/13/2008/ÅçÎí¼Á/¿¹Ñ×Ò©
(NDA # 022047)   QUETIAPINE FUMARATE¸»ÂíËáà­Áòƽ  ASTRAZENECA Manufacturing Change or Addition  03/13/2008/Ƭ¼ÁER/¾«Éñ·ÖÁÑÖ¢
(NDA # 050706)   MEROPENEMÃÀÂÞÅàÄÏ  ASTRAZENECA  Labeling Revision  03/13/2008/×¢Éä¼Á/¿¹ÉúËØ
(ANDA # 078564)   GRANISETRON HYDROCHLORIDEÑÎËá¸ñÀ­Ë¾Çí  WOCKHARDT  Tentative Approval  03/13/2008/×¢Éä¼Á/Ö¹ÍÂÒ©
(ANDA # 078902)   PAROXETINE HYDROCHLORIDEÑÎËáÅÁÂÞÎ÷Í¡  MYLAN  Approval  03/13/2008/Ƭ¼Á/¿¹ÒÖÓôÒ©
(NDA # 020986)   INSULIN ASPART RECOMBINANTÖØ×éÒȵºËØ  NOVO NORDISK INC  Patient Population Altered  03/14/2008/×¢Éä¼Á/½µÌÇÒ©(NDA # 021794)   DAPSONE°±±½í¿  QLT USA  Efficacy Supplement with Clinical Data to Support  03/14/2008/Äý½º¼Á/Ѱ³£ðî´¯
(ANDA # 077126)   AMIFOSTINE°¢Ã׸£Í¡ SUN PHARM INDS  Approval  03/14/2008/×¢Éä¼Á/¿¹Ö×Áö
3Â¥2008-04-03 16:24:00
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

xiaohezi7844

½ûÑÔ (ÖªÃû×÷¼Ò)

FDA08ÄêÈýÔÂÅú×¼µÄÒ©Æ·£¨Ï£©
*************************

(NDA # 020409) FLUNISOLIDE·úÄáËÉ  IVAX RES LLC  Manufacturing Change or Addition  03/17/2008/ÅçÎí¼Á/ÉöÉÏÏÙÆ¤Öʼ¤ËØ
(NDA # 022207)   MORPHINE SULFATEÁòËáÂð·È  ROXANE  Approval  03/17/2008/Ƭ¼Á/ÕòÍ´Ò©
(ANDA # 040723)   ISOSORBIDE DINITRATEÏõËáÒìɽÀæõ¥  COREPHARMA  Approval  03/17/2008/Ƭ¼Á£¨ER£©/ÐĽÊÍ´
(ANDA # 076128)   OFLOXACINÑõ·úɳÐÇ  BAUSCH AND LOMB  Approval  03/17/2008/µÎ¼Á/¿¹ÉúËØ
(ANDA # 076616)   OFLOXACINÑõ·úɳÐÇ  HI TECH PHARMA  Approval  03/17/2008/µÎ¼Á/¿¹ÉúËØ
(ANDA # 078222)   OFLOXACINÑõ·úɳÐÇ  ALCON  Approval  03/17/2008/µÎ¼Á/¿¹ÉúËØ
(ANDA # 078308)   ONDANSETRON HYDROCHLORIDEÑÎËá°ºµ¤Ë¾Çí  CLARIS LIFESCIENCES  Approval  03/17/2008/×¢Éä¼Á/Ö¹ÍÂÒ©
(ANDA # 077138)   CIPROFLOXACIN»·±ûɳÐÇ  TEVA PARENTERAL Approval  03/18/2008/×¢Éä¼Á/¿¹ÉúËØ
(ANDA # 077753)   CIPROFLOXACIN»·±ûɳÐÇ  HOSPIRA  Approval  03/18/2008/×¢Éä¼Á/¿¹ÉúËØ   
(ANDA # 077888)   CIPROFLOXACIN»·±ûɳÐÇ  BAXTER HLTHCARE Approval  03/18/2008/×¢Éä¼Á/¿¹ÉúËØ
(ANDA # 078024)   CIPROFLOXACIN»·±ûɳÐÇ  CLARIS LIFESCIENCES  Approval  03/18/2008/×¢Éä¼Á/¿¹ÉúËØ
(ANDA # 078114)   CIPROFLOXACIN»·±ûɳÐÇ  BEDFORD  Approval  03/18/2008/×¢Éä¼Á/¿¹ÉúËØ   
(ANDA # 078173)   RIZATRIPTAN BENZOATE±½¼×ËáÀûÔúÇú̹  MYLAN PHARMA  Tentative Approval  03/18/2008/¿Ú±ÀƬ/ƫͷʹ
(ANDA # 078252)   CIPROFLOXACIN»·±ûɳÐÇ ACS DOBFAR INFO SA Approval  03/18/2008/×¢Éä¼Á/¿¹ÉúËØ
(ANDA # 078476)   FOSPHENYTOIN SODIUMÁ×±½Í×Ӣį  AKORN STRIDES  Approval  03/18/2008/×¢Éä¼Á/¿¹ñ²ðïÒ©
(NDA # 021400)   VARDENAFIL HYDROCHLORIDEÑÎËá·¥µØÄÇ·Ç  BAYER HLTHCARE  Labeling Revision  03/19/2008/Ƭ¼Á/¿¹EDÒ©
(ANDA # 040587)   BENZONATATE±½×ôÄÇõ¥ SUN PHARM INDS INC Approval  03/19/2008/½ºÄÒ/Õò¿ÈÒ©
(ANDA # 065441)   CEFEPIME HYDROCHLORIDEÑÎËáÍ·æßßÁë¿  ACS DOBFAR  Approval  03/19/2008/×¢Éä¼Á/¿¹ÉúËØ
(ANDA # 077100)   DIVALPROEX SODIUMË«±ûÎìËáÄÆ  ZYDUS PHARMS USA  Tentative Approval  03/19/2008/Ƭ¼Á£¨DR£©/¿¹ñ²ðïÒ©
(NDA # 020692)   SALMETEROL XINAFOATEɳÃÀÌØÂÞôÇÝÁ¼×ËáÑΠ GLAXO GRP LTD  Labeling Revision  03/20/2008/·Û¼Á/ƽ´­Ò©
(NDA # 021223)   ZOLEDRONIC ACIDßòÀ´ì¢Ëá  NOVARTIS  Patient Population Altered  03/20/2008/×¢Éä¼Á/¿¹Ö×ÁöÒ©
(NDA # 021254)   FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE±ûËá·úÌæ¿¨ËÉ£¬É³ÃÀÌØÂÞôÇÝÁ¼×ËáÑΠ GLAXOSMITHKLINE  Labeling Revision  03/20/2008/ÅçÎí¼Á/ƽ´­Ò©
(NDA # 022056)   OMEPRAZOLE/°ÂÃÀÀ­ßò  ASTRAZENECA Approval  03/20/2008/»ìÐü¼Á/PPI  
(NDA # 022177)   STAVUDINE; LAMIVUDINE; NEVIRAPINE˾Ëû·ò¶¨/À­Ã×·ò¶¨/ÄÎΤÀ­Æ½  STRIDES ACROLAB  Tentative Approval  03/20/2008/Ƭ¼Á/¿¹°¬×ÌÒ©(NDA # 022249)   BENDAMUSTINE HYDROCHLORIDEÑÎËá±½´ïĪ˾͡   CEPHALON  Approval  03/20/2008/×¢Éä¼Á/°×Ѫ²¡
(ANDA # 040418)   ACETAMINOPHEN; HYDROCODONE BITARTRATE¶ÔÒÒõ£°±»ù·Ó£¬ÖؾÆÊ¯ËáÇâ¿Éͪ  MALLINCKRODT  Control Supplement  03/20/2008/¿Ú·þÈÜÒº¼Á/ÕòÍ´Ò©  
(ANDA # 040535)   ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE¶ÔÒÒõ£°±»ù·Ó£¬ÑÎËáÑõ¿Éͪ  WATSON LABS  Package Change  03/20/2008/Ƭ¼Á/ÕòÍ´Ò©        
(ANDA # 040813) ACETAMINOPHEN; HYDROCODONE BITARTRATE¶ÔÒÒõ£°±»ù·Ó£¬ÖؾÆÊ¯ËáÇâ¿Éͪ  INTERPHARM Packager Addition  03/20/2008/Ƭ¼Á/ÕòÍ´Ò©
(ANDA # 076642)   HYDROCODONE BITARTRATE; IBUPROFENÖØ¾ÆÊ¯ËáÇâ¿Éͪ£¬²¼Âå·Ò  INTERPHARM  Packager Addition  03/20/2008/Ƭ¼Á/ÕòÍ´Ò©
(ANDA # 076899)   SULFAMETHOXAZOLE; TRIMETHOPRIM»Ç°·¼×¶ñßò-¼×ÑõÜÐठ  INTERPHARM  Packager Addition  03/20/2008/Ƭ¼Á/¿¹ÉúËØ
(ANDA # 077094)   RIBAVIRINÀû°ÍΤÁÖ  ZYDUS PHARMS USA  Packaging Addition  03/20/2008/Ƭ¼Á/¿¹²¡¶¾Ò©
(ANDA # 077289)   CITALOPRAM HYDROBROMIDEÇâäåËáÎ÷̪ÆÕÀ¼  INTERPHARM  Packager Addition  03/20/2008/Ƭ¼Á/¿¹ÒÖÓôÒ©
(ANDA # 077743)   RIBAVIRINÀû°ÍΤÁÖ  SANDOZ  Control Supplement  03/20/2008/Ƭ¼Á/¿¹²¡¶¾Ò©        
(ANDA # 077779)   METOPROLOL SUCCINATE¾ÆÊ¯ËáÃÀÍÐÂå¶û KV PHARM  Approval  03/20/2008/Ƭ¼Á£¨ER£©/½µÑ¹Ò©
(ANDA # 077824)   RANITIDINE HYDROCHLORIDEÑÎËáÀ×ÄáÌæ¶¡  INTERPHARM  Packager Addition  03/20/2008/Ƭ¼Á/H2ÊÜÌåÞ׿¹¼Á
(ANDA # 077880)     METFORMIN HYDROCHLORIDEÑÎËá¶þ¼×Ë«ëÒ  INTERPHARM  Packager Addition  03/20/2008/Ƭ¼Á/½µÌÇÒ©
(ANDA # 078149)   ASPIRIN; BUTALBITAL; CAFFEINE°¢Ë¾Æ¥ÁÖ/²¼Ëû±ÈÍ×/¿§·ÈÒò  MUTUAL PHARM  Facility Addition  03/20/2008/½ºÄÒ/ÕòÍ´Ò©
(ANDA # 089883)   ACETAMINOPHEN; HYDROCODONE BITARTRATE¶ÔÒÒõ£°±»ù·Ó£¬ÖؾÆÊ¯ËáÇâ¿Éͪ WATSON LABS Manufacturing Revision  03/20/2008/Ƭ¼Á/ÕòÍ´Ò©
(NDA # 020232)   ACETAMINOPHEN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE¶ÔÒÒõ£°±»ù·Ó,²¼Ëû±ÈÍ×,¿§·ÈÒò,Á×Ëá¿É´ýÒò  WATSON PHARMS  Labeling Revision  03/21/2008/½ºÄÒ/ÕòÍ´Ò©
(NDA # 021235)   FLUOXETINE HYDROCHLORIDEÑÎËá·úÎ÷Í¡  LILLY  Labeling Revision  03/21/2008/¿Ú·þÈÜÒº/¿¹ÒÖÓôÒ©
(NDA # 021520)   FLUOXETINE HYDROCHLORIDE; OLANZAPINEÑÎËá·úÎ÷Í¡£»°ÂµªÆ½  LILLY  Labeling Revision  03/21/2008/½ºÄÒ/¿¹ÒÖÓôÒ©
(ANDA # 040847)   GLYCOPYRROLATE¸ñ¡äå°·  INDICUS PHARMA   Approval  03/21/2008/Ƭ¼Á/¿¹µ¨¼îÒ©
(ANDA # 040875)     PHENTERMINE HYDROCHLORIDEÑÎËá±½¶¡°·  KVK TECH  Approval  03/21/2008/½ºÄÒ/ʳÓûÒÖÖÆ¼Á
(ANDA # 078014)   ONDANSETRON HYDROCHLORIDEÑÎËá°ºµ¤Ë¾Çí  TARO PHARMS IRELAND  Approval  03/21/2008/×¢Éä¼Á/Ö¹ÍÂÒ©
(ANDA # 078926)     GABAPENTIN¼Ó°ÍÅç¶¡  ZYDUS PHARMS USA INC  Tentative Approval  03/21/2008/Ƭ¼Á/¿¹ñ²ðïÒ©
(NDA # 017531)   TRIMETHOBENZAMIDE HYDROCHLORIDEÑÎËáÈý¼×Ñõ±½õ£°· KING PHARMS  Labeling Revision  03/24/2008/½ºÄÒ/Êõºó¶ñÐÄÅ»ÍÂ
(NDA # 021168)   DIVALPROEX SODIUMË«±ûÎìËáÄÆ  ABBOTT  Patient Population Altered  03/24/2008/Ƭ¼Á£¨ER£©/¿¹ñ²ðïÒ©
(NDA # 021337)   ERTAPENEM SODIUM¶òËûÅàÄÏÄÆ  MERCK Labeling Revision  03/24/2008/×¢Éä¼Á/¿¹ÉúËØ
(NDA # 021777)   CYCLOBENZAPRINE HYDROCHLORIDEÑÎËá»·±½ÔúÁÖ  ANESTA  Labeling Revision  03/24/2008/½ºÄÒ£¨ER£©/¼¡ËÉÒ©
(NDA # 022267)   DIVALPROEX SODIUMË«±ûÎìËáÄÆ  ABBOTT   Approval  03/24/2008/Ƭ¼Á£¨ER£©/¿¹ñ²ðïÒ©
(NDA # 021567)   ATAZANAVIR SULFATEÁòËá°¢ÔúÄÇΤ  BRISTOL MYERS SQUIBB  Patient Population Altered  03/25/2008/½ºÄÒ/¿¹°¬×ÌÒ©
(BLA # 125019)   IBRITUMOMAB TIUXETANÒÁ¹  IDEC PHARMACEUTICALS CORP  Supplement  03/25/2008/×¢Éä¼Á/¿¹Ö×ÁöÒ©
(NDA # 020983)   ALBUTEROL SULFATEÁòËáɳ¶¡°·´¼   GLAXOSMITHKLINEEfficacy Supplement with Clinical Data to Support 03/26/2008/ÅçÎí¼Á/Ö§Æø¹Ü¾·ÂÎ
(ANDA # 065327)   CEFPROZILÍ·æß±ûÏ©  APOTEX INC Approval  03/26/2008/Ƭ¼Á/¿¹ÉúËØ
(ANDA # 076509)   FENOFIBRATE·Çŵ±´ÌØ  IMPAX LABS Approval  03/26/2008/Ƭ¼Á/½µÖ¬Ò©
(ANDA # 040704)   BETHANECHOL CHLORIDEÂȱ´¶¡õ¥ LANNETT Approval  03/27/2008/Ƭ¼Á/½µÖ¬Ò©
(NDA # 050706)   MEROPENEMÃÀÂÞÅàÄÏ ASTRAZENECA Labeling Revision  03/27/2008/×¢Éä¼Á/¿¹ÉúËØ
(NDA # 050726)   AMOXICILLIN; CLAVULANATE POTASSIUM°¢ÄªÎ÷ÁÖ/¿ËÀ­Î¬Ëá¼Ø  GLAXOSMITHKLINE  Labeling Revision  03/27/2008×¢Éä¼Á/¿¹ÉúËØ/¦Â-ÄÚõ£°·Àà/¦Â-ÄÚõ£°·Ã¸ÒÖÖÆ¼Á
(NDA # 050630)   CILASTATIN SODIUM; IMIPENEMÑǰ·ÅàÄÏÎ÷˾Ëû¶¡ÄÆ  MERCK  Labeling Revision  03/28/2008¾×½ÀƬ/¿¹ÉúËØ/¦Â-ÄÚõ£°·Àà/¦Â-ÄÚõ£°·Ã¸ÒÖÖÆ¼Á   
(NDA # 050761)   AMOXICILLIN°¢ÄªÎ÷ÁÖ  GLAXOSMITHKLINE  Labeling Revision  03/28/2008/¾×½ÀƬ/¿¹ÉúËØ
(ANDA # 065390)     RIFAMPINÀû¸£Æ½  LANNETT  Approval  03/28/2008/½ºÄÒ/¿¹ÉúËØ
(ANDA # 078525)   LAMOTRIGINEÀ­ÄªÈýຠ TARO PHARM INDS  Tentative Approval  03/28/2008/Ƭ¼Á/¿¹ñ²ðïÒ©
(NDA # 021319)   DUTASTERIDE¶ÈËûÐÛ°·  GLAXOSMITHKLINE  Labeling Revision  03/31/2008/½ºÄÒ¼Á/Á¼ÐÔǰÁÐÏÙÔöÉú£¨BPH£©
(NDA # 022009)   AVOBENZONE; ECAMSULE; OCTOCRYLENE; TITANIUM DIOXIDE°¢ÎÖ±½ËÉ/ÒÀÝ¨Êæ/°Â¿ËÁ¢ÁÖ/¶þÑõ»¯îÑ   LOREAL USA  Approval  03/31/2008/Èé¸àOTC/·Àɹ¼Á
(NDA # 022064)   LEVOCETIRIZINE DIHYDROCHLORIDEÑÎËá×óÐýÎ÷ÌæÀûຠ UCB INC  Labeling Revision  03/31/2008/Ƭ¼Á/H1ÊÜÌåÞ׿¹¼Á
(ANDA # 040842)   HYDROXYZINE HYDROCHLORIDEÑÎËáôÇÂð·Èͪ  NORTHSTAR HLTHCARE  Approval  03/31/2008/Ƭ¼Á/ÕòÍ´Ò©
(ANDA # 078084)     METRONIDAZOLE¼×Ïõßò CLARIS LIFESCIENCES  Approval  03/31/2008/×¢Éä¼Á/¿¹ÑáÑõ¾úÓ뿹µÎ³æÒ©
(ANDA # 040876)   PHENTERMINE HYDROCHLORIDEÑÎËá±½¶¡°· NORTHSTAR HLTHCARE  Approval  03/31/2008/Ƭ¼Á/ʳÓûÒÖÖÆ¼Á
(NDA # 020090)   FLUCONAZOLE·ú¿µßò  PFIZER  Labeling Revision  03/31/2008/¿Ú·þ»ìÐü¼Á/¿¹Õæ¾úÒ©
4Â¥2008-04-03 16:24:30
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

jiaruohuang

Òø³æ (СÓÐÃûÆø)

so many!!!!!
5Â¥2008-04-03 21:32:16
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ xiaohezi7844 µÄÖ÷Ìâ¸üÐÂ
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û